2023-12-15 2024-12-31 false Capium Accounts Production 1.1 15354765 2023-12-15 2024-12-31 15354765 bus:AbridgedAccounts 2023-12-15 2024-12-31 15354765 bus:FRS102 2023-12-15 2024-12-31 15354765 bus:AuditExemptWithAccountantsReport 2023-12-15 2024-12-31 15354765 bus:SmallCompaniesRegimeForAccounts 2023-12-15 2024-12-31 15354765 bus:PrivateLimitedCompanyLtd 2023-12-15 2024-12-31 15354765 2023-12-15 2024-12-31 15354765 2024-12-31 15354765 bus:RegisteredOffice 2023-12-15 2024-12-31 15354765 core:WithinOneYear 2024-12-31 15354765 core:AfterOneYear 2024-12-31 15354765 1 2023-12-15 2024-12-31 15354765 bus:Director1 2023-12-15 2024-12-31 15354765 bus:Director1 2024-12-31 15354765 bus:Director2 2023-12-15 2024-12-31 15354765 bus:Director2 2024-12-31 15354765 bus:Director3 2023-12-15 2024-12-31 15354765 bus:Director3 2024-12-31 15354765 bus:Director4 2023-12-15 2024-12-31 15354765 bus:Director4 2024-12-31 15354765 2022-12-15 15354765 bus:LeadAgentIfApplicable 2023-12-15 2024-12-31 15354765 2023-12-14 15354765 bus:OrdinaryShareClass1 2023-12-15 2024-12-31 15354765 bus:OrdinaryShareClass1 2024-12-31 15354765 core:PlantMachinery 2023-12-15 2024-12-31 15354765 core:PlantMachinery 2024-12-31 15354765 core:PlantMachinery 2023-12-14 15354765 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 15354765 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-14 15354765 core:OtherResidualIntangibleAssets 2023-12-15 2024-12-31 15354765 core:OtherResidualIntangibleAssets 2024-12-31 15354765 core:OtherResidualIntangibleAssets 2023-12-14 15354765 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 15354765 core:CostValuation core:Non-currentFinancialInstruments 2023-12-14 15354765 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 15354765 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 15354765 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 15354765 core:Non-currentFinancialInstruments 2024-12-31 15354765 core:Non-currentFinancialInstruments 2023-12-14 15354765 core:ShareCapital 2024-12-31 15354765 core:RetainedEarningsAccumulatedLosses 2024-12-31 15354765 dpl:Item1 2023-12-15 15354765 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15354765
England and Wales

 

 

 

MEDICANA WINCHESTER LIMITED



Abridged Accounts
 


Period of accounts

Start date: 15 December 2023

End date: 31 December 2024
 
 
Notes
 
2024
£
Fixed assets    
Intangible fixed assets 5 3,610 
Tangible fixed assets 6 61,164 
64,774 
Current assets    
Stocks 180,753 
Debtors: amounts falling due within one year 359,463 
Cash at bank and in hand 124,334 
664,550 
Creditors: amount falling due within one year (316,474)
Net current assets 348,076 
 
Total assets less current liabilities 412,850 
Creditors: amount falling due after more than one year (653,879)
Provisions for liabilities 73,591 
Net assets (167,438)
 

Capital and reserves
   
Called up share capital 7 1 
Profit and loss account (167,439)
Shareholders' funds (167,438)
 


For the period ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 25 June 2025 and were signed on its behalf by:


-------------------------------
CAN EMRE OZDEMIR
Director
1
General Information
MEDICANA WINCHESTER LIMITED is a private company, limited by shares, registered in England and Wales, registration number 15354765, registration address 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT. The trading address of the company is Chilcomb Park, Chilcomb Lane, Winchester, United Kingdom, SO21 1HU.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company net of trade discounts.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Light Medical Equipments 2
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Directors' Emoluments

2024

3.

Staff Costs

2024
£
Wages and salaries 281,593 
Other staff costs 24,442 
306,035 
Average number of employees during the period Number
Administration 34 
Marketing 1 
35 

4.

Average number of employees

Average number of employees during the period was 35.
5.

Intangible fixed assets

Cost Other intangible assets   Total
  £   £
At 15 December 2023  
Additions 3,610    3,610 
Disposals  
At 31 December 2024 3,610    3,610 
Amortisation
At 15 December 2023  
Charge for period  
On disposals  
At 31 December 2024  
Net book values
At 31 December 2024 3,610    3,610 
At 14 December 2023  


6.

Tangible fixed assets

Cost or valuation Plant and machinery etc   Total
  £   £
At 15 December 2023  
Additions 72,081    72,081 
Disposals  
At 31 December 2024 72,081    72,081 
Depreciation
At 15 December 2023  
Charge for period 10,917    10,917 
On disposals  
At 31 December 2024 10,917    10,917 
Net book values
Closing balance as at 31 December 2024 61,164    61,164 
Opening balance as at 15 December 2023  


7.

Share Capital

Allotted, called up and fully paid
2024
£
1 Class A share of £1.00 each

2